Syneos Health Signs Agreement with Siriraj Hospital to Support Clinical Trials in Thailand
April 18, 2024
MORRISVILLE, N.C., April 18, 2024 – Syneos Health®, a leading fully integrated biopharmaceutical solutions organization, has signed an agreement with Siriraj Hospital. The agreement expands the Company’s clinical trial capabilities across a broad range of therapeutic areas in Thailand.
Siriraj Hospital now becomes part of the Syneos Health Catalyst and Site Network Partnerships program, including 110+ clinical sites and 60+ commercial site networks. As part of the Site Network Partnerships program, Siriraj Hospital joins a select set of high-performing investigative site networks strategically aligned to Syneos Health’s clinical studies. Site Network Partnerships provide enhanced patient access, improved efficiencies, specialized expertise and access to diverse patient populations across all therapeutic areas and phases.
“When developing treatments, it is critical that a clinical trial represents all patient populations,” said Dr. Terttu Haring, President, Clinical Site & Patients, Syneos Health. “This is why collaborating with organizations such as Siriraj Hospital is vital. Together, we will open clinical trials for patients in Bangkok – offering access that was not present before and helping accelerate the development of therapies for patients worldwide.”
“We are thrilled to embark on this pivotal work with Syneos Health, which represents a moment of significance in advancing efficient and effective clinical research capabilities in our region. Our Catalyst site's ambition to establish itself at the forefront of Southeast Asia’s landscape for academic clinical research is immensely refined through this Catalyst program,” said Assoc. Prof. Winai Ratanasuwan, MD, Director of Siriraj Institute of Clinical Research, Faculty of Medicine Siriraj Hospital, Mahidol University.
About Syneos Health
Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities.
We bring together a talented team of professionals with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients.
Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.
To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com.
Press/Media Contact:
Meg Byers
Associate Director, External Communications
+1 607 215 1330
